Definitive Contract 75F40118C10172

This federal contract award issued by the Food and Drug Administration (FDA) to The Broad Institute, Inc. (doing business as Broad Institute of MIT and Harvard) is for a project titled "Comprehensive Spatio-Temporal Map of Gene Expression During Lethal Ebola Virus Disease". The $3,246,237.39 definitive contract has a performance period ending on Sep 30, 2023. The contract supports regulatory science and innovation research and development, as described in the FDA's Broad Agency Announcement solicitation. The Broad Institute is a non-profit biomedical and genomic research organization that partners with universities, medical centers, and companies on federally funded research projects. The institute frequently receives contract awards from agencies like the National Institutes of Health, Centers for Disease Control and Prevention, Department of Defense, and National Science Foundation to conduct specialized scientific services and translational research. This contract award has no set-aside designation.